Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer
In today's Pharmaceutical Executive Daily, Pfizer warns shareholders to reject an unsolicited mini-tender offer from Tutanota LLC seeking to purchase…
3 months, 2 weeks ago
Pharmaceutical Executive Daily: FDA Approves Wegovy HD
In today's Pharmaceutical Executive Daily, Novartis agrees to acquire a pan-mutant-selective inhibitor from Synnovation Therapeutics in a deal worth …
3 months, 3 weeks ago
The Ron Lanton Report: When Policy Becomes a Capital Event
The episode explores how regulatory signals across drug approvals, trade policy, AI governance, and drug pricing shape business strategy and investor…
3 months, 3 weeks ago
Pharmaceutical Executive Daily: Analysis on TrumpRx List Pricing
In today's Pharmaceutical Executive Daily, a new analysis finds that TrumpRx is listing prices for roughly a third of its featured drugs higher than …
3 months, 3 weeks ago
Pharmaceutical Executive Daily: Federal Judge Halts Vaccine Advisory Council Appointments
In today's Pharmaceutical Executive Daily, a federal judge blocks RFK Jr.'s reconstituted vaccine advisory committee and halts its policy changes, a …
3 months, 3 weeks ago
Pharmaceutical Executive Daily: Conflict in Middle East Disrupts Pharma Supply Chains
In today's Pharmaceutical Executive Daily, ongoing conflict in the Middle East is straining pharmaceutical supply routes to the Gulf region, Sentynl …
3 months, 3 weeks ago
Pharmaceutical Executive Daily: FDA Expands Approval for Arexvy
In today's Pharmaceutical Executive Daily, a new West Health-Gallup survey finds that more than 82 million Americans have cut back on daily expenses …
4 months ago
Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals
4 months ago
Moving CAR-T Beyond Oncology
Vincent Hennemand discusses using these types of therapies to develop treatments for autoimmune conditions.
4 months ago
Pharmaceutical Executive Daily: FDA's New Guidance for Biosimilar Development
In today's Pharmaceutical Executive Daily, the FDA issues new draft guidance aimed at reducing the cost and complexity of biosimilar development, Nov…
4 months ago